Qualigen Therapeutics Inc Ordinary Shares QLGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.40
- Day Range
- $0.36–0.40
- 52-Week Range
- $0.34–1.26
- Bid/Ask
- $0.39 / $0.40
- Market Cap
- $2.07 Mil
- Volume/Avg
- 79,534 / 64,459
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. It is a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics. The Company has viewed its operations and managed its business in one segment operating mainly within the United States and Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 38
- Website
- https://www.qualigeninc.com
Valuation
Metric
|
QLGN
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.39 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
QLGN
|
---|---|
Quick Ratio | 0.39 |
Current Ratio | 0.58 |
Interest Coverage | −14.79 |
Quick Ratio
QLGN
Profitability
Metric
|
QLGN
|
---|---|
Return on Assets (Normalized) | −94.74% |
Return on Equity (Normalized) | −289.88% |
Return on Invested Capital (Normalized) | −144.82% |
Return on Assets
QLGN
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qrrnlstbgq | Ksdt | $571.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Yfqwvrqp | Xpqtry | $107.8 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ycrlxmmt | Cgbtqql | $106.1 Bil | |
MRNA
| Moderna Inc | Rxrhxxt | Pdkh | $42.3 Bil | |
ARGX
| argenx SE ADR | Xvdwmxn | Swb | $23.7 Bil | |
BNTX
| BioNTech SE ADR | Qpjtxnjv | Bqj | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Gfvkgwfxf | Dyqlwvv | $19.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Gvvlfctvp | Gfnxjbt | $16.7 Bil | |
RPRX
| Royalty Pharma PLC Class A | Bdtnlqknxn | Kcmpb | $13.6 Bil | |
INCY
| Incyte Corp | Dwyxdgvm | Jwcwcpw | $12.8 Bil |